Background Carnitine deficiency may contribute to cardiovascular disease (CVD) in patients
with hemodialysis (HD). Dyslipidemia plays a role in CVD and its prevalence is also high in …

Background: It is well known that the physical activity in chronic hemodialysis patients
decreases compared to that in normal subjects. In order to investigate the effects of l …

Background l-carnitine is an amino acid derivative that is thought to be helpful for treating
renal anemia in hemodialysis patients. However, the mechanism remains to be fully …

L-Carnitine facilitates the entry of long-chain fatty acids into mitochondria, where they are
oxidized, producing energy for muscles and other cells. The pharmacology …

Purpose Carnitine deficiency is common in end-stage renal disease (ESRD) patients
receiving hemodialysis (HD) treatment. We investigated the effects of l-carnitine …

Patients on hemodialysis often have carnitine deficiency. We herein report a woman who
experienced the dramatic improvement of cardiac dysfunction after intravenous L-carnitine …

According to the review article on nutritional support in hemodialysis patients by Bossola et
al.[1], intradialytic parenteral nutrition (IDPN) seems to improve nutritional parameters such …

Background: Previously, we demonstrated that selected groups of hemodialysis patients
might be more likely to have abnormalities of carnitine metabolism. The purpose of the …

Among the homeostatic processes controlling the endogenous l-carnitine pool in humans,
the kidney has a vital role through extensive and adaptive tubular reabsorption. Kidney …